T2-Pseudonormalization and Microstructural Characterization in Advanced Stages of Late-infantile Metachromatic

Pascal Martin1, Gisela E Hagberg2,3, Thomas Schultz4

  • 1Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. pascal.martin@med.uni-tuebingen.de.

Clinical Neuroradiology
|November 23, 2020
PubMed
Abstract

Insights

In late-infantile metachromatic leukodystrophy (MLD), T2-pseudonormalization in white matter (WM) indicates advanced disease. This MRI finding masks severe microstructural abnormalities, including myelin and neuronal loss.

Area of Science:

  • Neurology
  • Radiology
  • Biochemistry

Background:

  • T2-weighted signal hyperintensities in white matter (WM) are a key MRI finding in metachromatic leukodystrophy (MLD).
  • Understanding the evolution of these hyperintensities is crucial for assessing disease progression and treatment efficacy.

Purpose of the Study:

  • To describe and characterize T2-pseudonormalization in the advanced stage of late-infantile MLD.
  • To investigate WM microstructure in areas exhibiting T2-pseudonormalization using multimodal MRI.

Main Methods:

  • Quantified T2-hyperintensity volume in 27 children with late-infantile MLD.
  • Conducted multimodal MRI (diffusion-weighted imaging, MRS, MWF, MTR, T1-mapping, QSM) on three children with advanced disease and T2-pseudonormalization.

Main Results:

  • Observed normalization of T2-hyperintensities in cerebral WM in three advanced-stage MLD patients.
  • Multimodal MRI revealed significantly decreased NAA, neurite density, MWF, MTR, and increased radial diffusivity in T2-pseudonormalized areas.

Conclusions:

  • T2-pseudonormalization in late-infantile MLD signifies severe WM microstructural abnormalities, including myelin and neuronal loss, gliosis, and storage material.
  • Multimodal MRI protocols with specific microstructural parameters are recommended over T2-weighted sequences for evaluating MLD treatment trials.